Breast cancer patients with very high tumor HER2 expression levels might not benefit from treatment with trastzumab plus chemotherapy: A retrospective exploratory analysis of the FinHer trial

Aktiviteetti: Konferenssiesitelmä

Description

Contributors: Joensuu H, Sperinde J, Leinonen M, Huang W, Weidler J, Bono P, isola J, Kellokumpu-Lehtinen P, Bates M,